Related Experiment Video
Updated: Aug 12, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
[Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%]
J F Ramos-López1, R Martínez-Costa Pérez, A L Cisneros Lanuza
1Hospital Universitario La Fe y Fundación Oftalmológica del Mediterráneo (FOM), Valencia, España. juanframos@oftalmogranada.com
Purpose:
To evaluate the efficacy of topical mitomycin C (MMC) 0.02% in treating conjunctival intraepithelial neoplasia (CIN).
Methods:
Three patients with CIN were treated with topical MMC 0.02%. Our follow-up period was twelve months (range 8-18 months).
Results:
CIN was resolved in all three cases without modifying the normal corneal and conjunctival architecture.
Conclusions:
Topical MMC 0.02% four times daily during two weeks is a useful alternative tool for the surgical management of CIN.
More Related Videos
06:15Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
04:48Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024